Search Results - "Kotch, Chelsea"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Neurofibromatosis type 1-associated gliomas and other tumors: A new pathway forward? by Webster Carrion, Andrea, Shah, Amish C., Kotch, Chelsea

    Published in Pediatric hematology oncology journal (01-06-2023)
    “…Neurofibromatosis type 1 (NF1) is an autosomal dominant cancer predisposition syndrome caused by germline alterations of the NF1 gene. Patients with NF1 are at…”
    Get full text
    Journal Article
  2. 2

    Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma by Kim, Kristine N, Shah, Yash B, Croy, Colleen, Lustig, Robert A, LaRiviere, Michael, Kotch, Chelsea

    Published in Journal of oncology pharmacy practice (01-03-2023)
    “…Introduction Memantine is used for neurocognitive protection in patients undergoing cranial radiotherapy for central nervous system tumors and is reported to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome by Kotch, Chelsea, Barrett, David, Teachey, David T

    Published in Expert review of clinical immunology (03-08-2019)
    “…: Cancer-directed immunotherapies are transforming the landscape in oncology as new and exciting therapies move from the laboratory to the bedside. Chimeric…”
    Get more information
    Journal Article
  5. 5
  6. 6

    The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System Tumors by Kotch, Chelsea, Elgarten, Caitlin W., McWhorter, Jessica, Schmus, Cynthia, Wilhelm, Darielle, Li, Yimei, Minturn, Jane E.

    Published in Journal of pediatric hematology/oncology (08-06-2023)
    “…Young children undergoing treatment with intensive chemotherapy for high-grade central nervous system (CNS) tumors are at risk for malnutrition, yet no…”
    Get full text
    Journal Article
  7. 7

    Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1 by Kotch, Chelsea, Dombi, Eva, Shah, Amish C., Smith, Katherine, Brown, Symone, Li, Yimei, Widemann, Brigitte C., Fisher, Michael J.

    Published in The Journal of pediatrics (01-09-2023)
    “…To assess the hypothesis that plexiform neurofibroma (PN) growth rates increase during puberty. PN growth rates before and during puberty were compared in a…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions by Kotch, Chelsea, de Blank, Peter, Gutmann, David H., Fisher, Michael J.

    Published in Child's nervous system (01-10-2024)
    “…Neurofibromatosis type 1 (NF1) is an autosomal dominant cancer predisposition syndrome characterized by the development of both central and peripheral nervous…”
    Get full text
    Journal Article
  12. 12

    The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System Tumors by Kotch, Chelsea, Elgarten, Caitlin W., McWhorter, Jessica, Schmus, Cynthia, Wilhelm, Darielle, Li, Yimei, Minturn, Jane E.

    Published in Journal of pediatric hematology/oncology (01-08-2023)
    “…Young children undergoing treatment with intensive chemotherapy for high-grade central nervous system (CNS) tumors are at risk for malnutrition, yet no…”
    Get full text
    Journal Article
  13. 13

    Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities by Kotch, Chelsea, Friedman, David F, Wilkins, Benjamin J, Samelson-Jones, Benjamin J

    Published in Pediatrics (Evanston) (01-02-2021)
    “…Alloimmune hemolytic disease of the fetus or newborn (HDFN) is a rare cause of neonatal cholestasis. HDFN-associated cholestasis has most often been reported…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1 by Kotch, Chelsea, Avery, Robert, Getz, Kelly D, Bouffet, Eric, de Blank, Peter, Listernick, Robert, Gutmann, David H, Bornhorst, Miriam, Campen, Cynthia, Liu, Grant T, Aplenc, Richard, Li, Yimei, Fisher, Michael J

    Published in Neuro-oncology (Charlottesville, Va.) (01-08-2022)
    “…Abstract Background Nearly one-third of patients with neurofibromatosis type 1-associated optic pathway glioma (NF1-OPG) fail frontline chemotherapy; however,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis by Kotch, Chelsea, Fisher, Michael J, Lin, Fumin, Zhong, Yiming, Gallo, Dan, Fan, Zhiqian, Chen, Jiani, Santi, Mariarita, Li, Marilyn M

    Published in Cancer genetics (01-04-2022)
    “…•Pathogenic germline NF2 mutation was identified in a patient with atypical teratoid rhabdoid tumor.•Chromosome with germline deletion of NF2 acquired a…”
    Get full text
    Journal Article
  20. 20

    Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study by Kotch, Chelsea, Wagner, Kristina, Broad, J Harris, Dombi, Eva, Minturn, Jane E, Phillips, Peter, Smith, Katherine, Li, Yimei, Jacobs, Ian N, Elden, Lisa M, Fisher, Michael J, Belasco, Jean

    Published in Cancers (05-05-2023)
    “…Limited therapies exist for neurofibromatosis type 1 (NF1)-associated plexiform neurofibroma (PN). For this reason, the activity of vinblastine (VBL) and…”
    Get full text
    Journal Article